Login
← Go Back
Bharat Immunologicals & Biologicals Corporation
BHIMMUN&BIO · Pharma > Pharmaceuticals & Drugs
Stock Price vs Company Growth
1d
0.1%
1w
0.7%
1m
4.3%
3m
0.7%
6m
15.0%
1y
29.7%
5y
24.4%
10y
2.0%
all
2.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 16.7 0.1%
16
20.2
Company Overview
Sales
26.5 Cr
Growth: -28.9%
Profit after Tax
-17.3 Cr
Growth: -0.5%
Micro Cap
72 Cr
P/S: 2.7x
Industry P/S: 2.7x
Fundamentals
Sales (Cr) ₹ 26.5
Growth -28.9%
EBITDA N/A
P/S 2.7x
Dividend 0.0%
P/E -4.1x
Book Value ₹ 10
PEG Ratio 0.1x
ROE -40.0%
P/B N/A
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
:The Company's principal activity is to manufacture and supply of oral polio vaccine. It supplies oral polio vaccine to Government of India. Its plant is located in Bulandshahr, Uttar Pradesh.The live oral polio vaccine (OPV) is a trivalent vaccine containing suspensions of type 1,2 and 3 attenuated poliomyelitis viruses (Sabin strains) prepared in primary moneky kidney cell culture. Each dose contains Poliovirus type 1 = 106.0Poliovirus type 2 = 105.0Poliovirus type 3 = 105.